Figure 5.
Anti-KEL antibodies induce complement fixation on KELlo, KELmed, and KELhiRBCs. (A-D) KELlo (green), KELmed (blue), and KELhi (red) RBCs were examined for active complement components (C3/C3b/iC3b) deposition by flow cytometry at 10 minutes, and 1, 2, 4, 6, and 24 hours posttransfusion into low, medium (med), or high (hi) αKEL immunized recipients. (E-H) KELlo (green), KELmed (blue), and KELhi (red) RBCs were examined for total complement component 3 (C3) deposition by flow cytometry at 10 minutes, and 1, 2, 4, 6, and 24 hours posttransfusion into low, medium (med), or high (hi) αKEL immunized recipients. *Significance indicated vs value at 10 minutes posttransfusion. P < .05. Error bars represent mean ± SEM. n = 5-7 mice per group. Each panel represents data reproduced 3 times.

Anti-KEL antibodies induce complement fixation on KELlo, KELmed, and KELhiRBCs. (A-D) KELlo (green), KELmed (blue), and KELhi (red) RBCs were examined for active complement components (C3/C3b/iC3b) deposition by flow cytometry at 10 minutes, and 1, 2, 4, 6, and 24 hours posttransfusion into low, medium (med), or high (hi) αKEL immunized recipients. (E-H) KELlo (green), KELmed (blue), and KELhi (red) RBCs were examined for total complement component 3 (C3) deposition by flow cytometry at 10 minutes, and 1, 2, 4, 6, and 24 hours posttransfusion into low, medium (med), or high (hi) αKEL immunized recipients. *Significance indicated vs value at 10 minutes posttransfusion. P < .05. Error bars represent mean ± SEM. n = 5-7 mice per group. Each panel represents data reproduced 3 times.

Close Modal

or Create an Account

Close Modal
Close Modal